Bmc Nephrology

Bmc Nephrology

Bmc 肾内科

  • 4区 中科院分区
  • Q2 JCR分区

期刊简介

《Bmc Nephrology》是由BioMed Central出版社于2000年创办的英文国际期刊(ISSN: 1471-2369,E-ISSN: 1471-2369),该期刊长期致力于泌尿学与肾脏学领域的创新研究,主要研究方向为UROLOGY & NEPHROLOGY。作为SCIE收录期刊(JCR分区 Q2,中科院 4区),本刊采用OA开放获取模式(OA占比1%),以发表泌尿学与肾脏学领域等方向的原创性研究为核心(研究类文章占比89.92%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在377篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Bmc Nephrology审稿周期约为 一般,3-8周 。该刊近年未被列入国际预警名单,年发文量约377篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 377 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
UROLOGY & NEPHROLOGY 泌尿学与肾脏学
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
UROLOGY & NEPHROLOGY 泌尿学与肾脏学
4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:UROLOGY & NEPHROLOGY SCIE Q2 54 / 126

57.5%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:UROLOGY & NEPHROLOGY SCIE Q2 43 / 126

66.27%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:4.3 SJR:0.697 SNIP:0.907
学科类别 分区 排名 百分位
大类:Medicine 小类:Nephrology Q2 29 / 81

64%

期刊发文

  • A Metabolomics study of metabolites associated with the glomerular filtration rate

    Author: Peng, Hongquan; Liu, Xun; Ieong, Chiwa Ao; Tou, Tou; Tsai, Tsungyang; Zhu, Haibin; Liu, Zhi; Liu, Peijia

    Journal: BMC NEPHROLOGY. 2023; Vol. 24, Issue 1, pp. -. DOI: 10.1186/s12882-023-03147-9

  • Correlation between the increase in serum uric acid and the rapid decline in kidney function in adults with normal kidney function: a retrospective study in Urumqi, China

    Author: Li, Na; Yang, Xiaoping; Wu, Jianrong; Wang, Yinghong; Wang, Zengliang; Mu, Huyati

    Journal: BMC NEPHROLOGY. 2023; Vol. 24, Issue 1, pp. -. DOI: 10.1186/s12882-023-03151-z

  • Prevalence and predisposing factors of depressive symptoms in continuous ambulatory peritoneal dialysis patients: a cross-sectional single center study

    Author: Chen, Yu; Li, Peng; Zhang, Lei; Zhang, Yanfei; Xie, Luyi; Niu, Jianying

    Journal: BMC NEPHROLOGY. 2023; Vol. 24, Issue 1, pp. -. DOI: 10.1186/s12882-023-03166-6

  • SGLT-2 inhibitors may increase ultrafiltration in incident peritoneal dialysis patients: a case report

    Author: Lai, Jia-Wen; Lin, Hsuan-Jen; Chou, Che-Yi

    Journal: BMC NEPHROLOGY. 2023; Vol. 24, Issue 1, pp. -. DOI: 10.1186/s12882-023-03164-8

  • Risk factors of immune checkpoint inhibitor-associated acute kidney injury: evidence from clinical studies and FDA pharmacovigilance database

    Author: Chen, Pengwei; Zhu, Jianhong; Xu, Yanchun; Huang, Qiuyan; Su, Jianan; Gao, Ziqing; Feng, Min

    Journal: BMC NEPHROLOGY. 2023; Vol. 24, Issue 1, pp. -. DOI: 10.1186/s12882-023-03171-9

  • Effect of high density lipoprotein cholesterol (HDL-C) on renal outcome in patients with nephrotic syndrome complicated with steroid-induced diabetes mellitus(SIDM)

    Author: Li, Jiarong; Hui, Di; Yang, Liu; Hou, Jinhua; Xie, Honglang

    Journal: BMC NEPHROLOGY. 2023; Vol. 24, Issue 1, pp. -. DOI: 10.1186/s12882-022-03042-9

  • Efficacy of low-dose rituximab in minimal change disease and prevention of relapse

    Author: Zhang, Jian; Zhao, Hui; Li, Xiaoli; Qian, Rui; Gao, Peijuan; Lu, Shouyan; Ma, Zhigang

    Journal: BMC NEPHROLOGY. 2023; Vol. 24, Issue 1, pp. -. DOI: 10.1186/s12882-023-03092-7

  • Intra-dialytic blood pressure variability is a greater predictor of cardiovascular events in hemodialysis patients

    Author: Liu, Qixing; Wang, Wei; Wu, Xianglan; Lv, Jiaxuan; Cai, Shiming; Li, Yuehong

    Journal: BMC NEPHROLOGY. 2023; Vol. 24, Issue 1, pp. -. DOI: 10.1186/s12882-023-03162-w